BridgeBio Pharma, Inc. (BBIO)
67.52
-0.09
(-0.13%)
USD |
NASDAQ |
Jun 08, 15:40
BridgeBio Pharma Profit Margin (Quarterly) : -85.63% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc. | 18.75% |
| Alnylam Pharmaceuticals, Inc. | 17.65% |
| Ionis Pharmaceuticals, Inc. | -37.60% |
| BioMarin Pharmaceutical, Inc. | 13.55% |
| Cytokinetics, Inc. | -1.06K% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -69.29% |
| Return on Invested Capital | -87.57% |
| Gross Profit Margin (Quarterly) | 94.64% |
| Operating Margin (Quarterly) | -54.47% |
| Return on Net Operating Assets | -374.1% |